Oak Associates LTD Novartis Ag Transaction History

Oak Associates LTD

$1.48 Billion
Q3 2024

A detailed history of Oak Associates LTD transactions in Novartis Ag stock. As of the latest transaction made, Oak Associates LTD holds 152,034 shares of NVS stock, worth $15 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

152,034

Previous 151,507 0.35%

Holding current value

$15 Million

Previous $16.1 Million 8.41%

% of portfolio

1.18%

Previous 1.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $55,930 - $63,709	527 Added 0.35%	152,034 $17.5 Million
Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $60,263 - $69,897	-651 Reduced 0.43%	151,507 $16.1 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $64,307 - $73,217	-675 Reduced 0.44%	152,158 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $442,342 - $486,782	4,794 Added 3.24%	152,833 $15.4 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $218,352 - $242,324	2,305 Added 1.58%	148,039 $15.1 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $2.87 Million - $3.25 Million	-31,025 Reduced 17.55%	145,734 $14.7 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $81,390 - $94,387	1,017 Added 0.58%	176,759 $16.3 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $705,637 - $864,136	-9,340 Reduced 5.05%	175,742 $15.9 Million
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $1.65 Million - $1.93 Million	-22,092 Reduced 10.66%	185,082 $14.1 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $148,639 - $173,062	-1,846 Reduced 0.88%	207,174 $17.5 Million
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $356,809 - $403,621	-4,454 Reduced 2.09%	209,020 $18.3 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $127,838 - $141,360	-1,604 Reduced 0.75%	213,474 $18.7 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $106,550 - $117,687	-1,250 Reduced 0.58%	215,078 $19.6 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $1.93 Million - $2.27 Million	-23,099 Reduced 9.65%	216,328 $18.5 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $305,971 - $338,975	-3,725 Reduced 1.53%	239,427 $20.8 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $254,201 - $286,145	-3,141 Reduced 1.28%	243,152 $21.2 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $179,572 - $251,584	-2,541 Reduced 1.02%	246,293 $20.3 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $440,306 - $497,831	-5,220 Reduced 2.05%	248,834 $23.6 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $130,362 - $143,652	-1,524 Reduced 0.6%	254,054 $22.1 Million
Q2 2019 Aug 09, 2019	BUY	$75.4 - $92.8 $3.43 Million - $4.22 Million	45,485 Added 21.65%	255,578 $23.3 Million
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $2.91 Million - $3.33 Million	38,684 Added 22.57%	210,093 $20.2 Million
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $132,735 - $147,800	-1,802 Reduced 1.04%	171,409 $14.7 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $1.16 Million - $1.35 Million	17,396 Added 11.16%	173,211 $14.9 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $9.15 Million - $10.3 Million	140,915 Added 945.74%	155,815 $11.8 Million
Q4 2017 Feb 08, 2018	BUY	$72.33 - $77.64 $1.08 Million - $1.16 Million	14,900	14,900 $1.25 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Account

Oak Associates LTD Novartis Ag Transaction History